bf/NASDAQ:RIGL_icon.jpeg

NASDAQ:RIGL

Rigel Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.96

21/06 20:00

Market Cap

224.94M

Beta: 0.73

Volume Today

764.69K

Avg: 2.73M

PE Ratio

−8.04

PFCF: −5.71

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.rigel.com
  • ipo date

    Nov 29, 2000

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for t...Show More

Earnings

Earnings per Share (Estimate*)

-0.2-0.10.10.22015-03-032017-03-072019-02-282021-03-022023-03-07

Revenue (Estimate*)

500M1B1.50B2015-03-032017-03-072019-02-282021-03-022023-03-07

*Estimate based on analyst consensus